Download September - the St. Louis Optometric Society

September, 2012
NEXT MEETING
Tuesday, September 11
MISSOURI OPTOMETRIC ASSOCIATION
2012 ANNUAL CONVENTION
October 11-14
“More Than Meets the Eye”
St. Louis Marriott West
660 Maryville Centre Drive
6:00 p.m.
Light buffet
Hosted by Paragon Vision Services
RSVP by Thursday, September 6
7:00 p.m.
Business Meeting
7:30 p.m.
“Contact Lens Myopia Control”
Jeffrey Walline, O.D., Ph.D.
One hour C.E.
CORNEAL REFRACTIVE THERAPY
Dr. Walline will discuss all forms of myopia
control, including eye drops, bifocal spectacles,
under-correction, and gas permeable contact
lenses. These forms of myopia control will be
compared to corneal reshaping and soft bifocal
contact lenses in order to put the potential of
contact lenses for myopia control into perspective.
A discussion of the theory of contact lens
myopia control will better enable eye care
practitioners to optimally prescribe for myopia
control. Iinformation about fitting kids with contact
lenses will enhance eye care practitioners’ ability
to fit young children with contact lenses.
A graduate of the California, Berkely School of
Optometry, Dr. Walline received his Master’s
degree in Physiological Optics and a PhD. Degree
in Vision Science from the Ohio State University
College of Optometry where he is now an
instructor in the Bionocular Vision and Pediatrics
and Contact Lens Services . this promises to be
an interesting and informative presentation.
Reservations by September 6, please.
#####
Chateau on the Lake – Branson, Missouri
Visit moeyecare.org
For details and registration on line
#####
NEW SLOS MEMBERS
Drs. Barbara Balabas and Nathan Dieckow
St. Louis Optometric Society
Officers: 2011-2012
President
Paul A. Whitten, O.D.
314 839-2400
President-Elect
Jason Riley, O.D.
573 468-4032
Vice President
Scott Tomasino, O.D.
636 272-1444
Secretary
Kimberly Layfield, O.D.
314 739-9293
Treasurer
Erin Niehoff, O.D.
636 528-2020
Sgt. At Arms
Joseph Castellano, O.D.
314 863-0000
Immediate Past President
Karen Rosen, O.D.
314 843-2020
MOA Trustees
Tom Cullinane, O.D.
314 579-0909
Robert G. Goerss, O.D.
636 272-1444
Executive Director
Barbara Nahlik
Phone: 314 725-2020
FAX 314 961-1041
e-mail: [email protected]
FROM THE AUGUST 14 SLOS MEETING…
Dr. Tom Hobbs, optometrist from Warrensburg,
MO, presented the continuing education for the
August SLOS meeting. The topic was “Eyes on
Fabry.”
Fabry Disease is a silently progressive,
increasingly debilitating, often life-threatening
genetic disorder. It affects both males and
females of all ethnicities and ages, and is a
metabolic disorder that is part of the larger family
of lysosomal storage disorders. Progressive
cellular substrate accumulation begins before
birth and leads to debilitating symptoms and lifethreatening complications. It can be challenging
to identify, but is easy to diagnose.
In Fabry Disease, a deficiency of the lysosomal
enzyme alpha-galactosidase A (α-GAL) leads to
Dr. Tom Hobbs discussed Fabry Disease
progressive substrate accumulation of
globotriaosylceramide (GL-3). Over time, the
build-up can cause irreversible organ damage and
death. The multisystemic signs and symptoms
begin to show in childhood and adolescence.
This can eventually lead to renal failure, heart
disease, and stroke.
Fabry Disease is an X-linked (dominant) disease
as the α-GAL gene is located on the X
chromosome. Therefore, males with the defective
gene are always affected and females with the
defective gene are affected to varying degrees,
possibly due to skewed X inactivation. Also,
affected fathers will pass the gene to all
daughters, but no sons. Affected mothers have a
50% risk of passing the defective gene to both
sons and daughters.
As GL-3 accumulates, signs and symptoms may
begin in childhood. These include episodic pain
crises, neuropathic pain, hypohidrosis/anhidrosis,
corneal and lenticular opacities, recurrent fever,
heat and cold intolerance, psychosocial
manifestations, and gastrointestinal distress.
During adolescence, proteinuria, angiokeratomas,
and fatigue may also begin to develop. Finally in
adulthood, more life-threatening manifestations
can arise including renal insufficiency,
neurological complications, cerebrovascular
disease, cardiac dysfunction, and hearing
loss/tinnitus.
Continued on next page
Fabry Disease
As mentioned before, the ocular manifestations
include corneal and lenticular opacities. The
cornea develops whorl-like rays that are only
visible by slit-lamp and usually do not affect
vision. These signs are a very useful diagnostic
indicator and are found almost universally in
males and approximately 70% of females.
Early recognition of the disease is important.
Even though the disease usually presents in
childhood, it often goes unrecognized until
adulthood when underlying pathology is
advanced. Patients may see a range of
specialists before the disease is recognized and
delayed diagnosis may be due to underrecognition of early signs and symptoms. One
problem is that the symptoms of Fabry disease
are similar to those of other more common
disorders. The most common misdiagnoses may
include rheumatoid or juvenile arthritis, rheumatic
fever, erythromelagia, neurosis, “growing pains”,
Raynaud’s syndrome, multiple sclerosis, and
petechiae.
Fabry disease management consists of
supportive therapy, regular ongoing follow-up and
disease specific intervention. Enzyme
replacement therapy is one intervention that helps
to slow the progression of the disease.
Diagnosing a single Fabry patient is also
important because it also means a Fabry family is
being identified. The earlier the diagnosis is
made the greater chance of preventing
irreversible organ damage.
Dr. Hobb’s presentation was co-sponsored by
Fabry Support and Information Group
(www.fabry.org) and SLOS.
Resources and support: www.fabry.org,
www.fabrycommunity.com,
www.fabryregistry.com, www.genetests.org.
#####
Fabry patients, Jack Johnson of FSIG and
Amanda Luchento with Tanya Downing of Gensyme
THANKS FOR THE UM-SL COLLEGE OF OPTOMETRY
MOBILE EYECARE UNIT THAT PROVIDED THE SLIT
LAMPS FOR FABRY PATIENT OBSERVATION
Members lined up to observe the patients
Observing the Fabry patient
Sept. 5
*******
CALENDAR
*******
Vision Summer Seminar
Mason Bias, M.D.
2 hrs. C.E.
Sept. 11
SLOS Meeting
Jeffrey Walline, O.D., Ph.D.
“Contact Lens Myopia Control”
Hosted by Paragon Vision Services
Oct. 9
SLOS Meeting
Dr. Larry Alexander
Oct. 11-14
MOA Convention
Chateau on the Lake, Branson, MO
Nov. 13
SLOS Meeting
Pepose Vision Institute
Dec. 11
Holiday Party
Hosted by Midland Optical
#####
SLOS COMMITTEES FOR 2012-2013
Contact Lenses:
Dan Friederich
Jordan Jones
Co-Management: Drew Biondo
New Technology: Christy Hayes
Jamie Gold
Membership:
Barb Aalbers
Kim Folwarski
Marissa O’Brien
#####
Drs. Jamie Gold, Jessica Carson & Jordan Jones
VISIT THE SLOS WEBSITE
www.stlouisoptometricsociety.org
FABRY SUPPORT & INFORMATION GROUP
The FSIG mission is to provide the Fabry community
and the general public with information, advocacy,
education and compassionate support to improve the
quality of life and the quality of care for Fabry patients
and family members.
FSIG strives to raise awareness of Fabry disease and
it’s symptoms within and for the Fabry patient, family
members, caregivers, medical and therapeutic communities as well as the general public. Increased
knowledge and awareness of this rare hereditary
genetic condition. FSIG is a 501(c)(3) nonprofit
organization. Visit: www.fabry-org
#####
OPTOMETRIST WANTED – private Practice setting
in Lincoln & Pike Counties. Full or Part Time.
Dr, Denise Harvey, Office: 573-324-3131 or
Cell: 573 470-1615